Is lisinopril a beta blocker drug
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Is Lisinopril a Beta Blocker Drug?
Understanding Lisinopril: ACE Inhibitor
Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor, not a beta blocker. ACE inhibitors like lisinopril work by relaxing blood vessels, which helps to lower blood pressure and improve blood flow. This class of drugs is commonly used to treat conditions such as hypertension and congestive heart failure .
Beta Blockers: A Different Mechanism
Beta blockers, on the other hand, work by blocking the effects of the hormone epinephrine, also known as adrenaline. This action helps to slow down the heart rate and reduce blood pressure. Common beta blockers include atenolol and carvedilol, which are often used in combination with other medications like ACE inhibitors for enhanced therapeutic effects .
Combined Use in Hypertension and Heart Failure
Studies have shown that combining an ACE inhibitor like lisinopril with a beta blocker can provide significant benefits in managing hypertension and heart failure. For instance, a study demonstrated that the combination of atenolol (a beta blocker) and lisinopril resulted in a greater reduction in blood pressure compared to either drug alone. Another study found that adding atenolol to lisinopril therapy significantly improved left ventricular contractility in cases of chronic mitral regurgitation.
Cardiotoxicity Prevention in Cancer Treatment
In the context of cancer treatment, particularly for patients receiving trastuzumab, both ACE inhibitors and beta blockers have been studied for their potential to prevent cardiotoxicity. Research indicates that both lisinopril and carvedilol (a beta blocker) can reduce the incidence of cardiotoxicity and minimize treatment interruptions in patients undergoing chemotherapy .
Conclusion
In summary, lisinopril is an ACE inhibitor, not a beta blocker. While both types of drugs are used to treat similar cardiovascular conditions, they operate through different mechanisms. The combination of ACE inhibitors and beta blockers can offer enhanced benefits in managing hypertension and heart failure, as well as in preventing cardiotoxicity in cancer patients.
Sources and full results
Most relevant research papers on this topic